March 18, 2020 – Pfizer Canada takes seriously the presence of the novel coronavirus (COVID-19) in Canada. In this troubling time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. We are closely monitoring the impact of COVID-19 on our supply chain and as of now, we have not seen any disruption or impact to our business. We are working to ensure continued access of our medicines and vaccines to patients across Canada.
|19 March 2020|